Detalles de la búsqueda
1.
Empagliflozin in women with type 2 diabetes and cardiovascular disease - an analysis of EMPA-REG OUTCOME®.
Diabetologia
; 61(7): 1522-1527, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29713728
2.
Risk of hypoglycaemia in people aged ≥65 years receiving linagliptin: pooled data from 1489 individuals with type 2 diabetes mellitus.
Int J Clin Pract
; 72(10): e13240, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30216648
3.
Impact of empagliflozin on blood pressure in dipper and non-dipper patients with type 2 diabetes mellitus and hypertension.
Diabetes Obes Metab
; 19(11): 1620-1624, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28387058
4.
Kidney Disease End Points in a Pooled Analysis of Individual Patient-Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 Diabetes.
Am J Kidney Dis
; 66(3): 441-9, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25960304
5.
Improvement in Cardiovascular Outcomes With Empagliflozin Is Independent of Glycemic Control.
Circulation
; 138(17): 1904-1907, 2018 10 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-30354665
6.
Cardiovascular Outcomes and Safety of Empagliflozin in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: A Subanalysis of EMPA-REG OUTCOME.
Circulation
; 137(4): 405-407, 2018 01 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29133602
7.
Hemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin with renin-angiotensin system inhibitors in type 2 diabetic patients with albuminuria.
J Hypertens
; 37(6): 1294-1300, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30540657
8.
Efficacy and Safety of Linagliptin in 2681 Asian Patients Stratified by Age, Obesity, and Renal Function: A Pooled Analysis of Randomized Clinical Trials.
Adv Ther
; 34(9): 2150-2162, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28819835
9.
Efficacy and safety of linagliptin/metformin single-pill combination as initial therapy in drug-naïve Asian patients with type 2 diabetes.
Diabetes Res Clin Pract
; 124: 48-56, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28088030
10.
Safety and efficacy of linagliptin in patients with type 2 diabetes mellitus and coronary artery disease: Analysis of pooled events from 19 clinical trials.
J Diabetes Complications
; 30(7): 1378-84, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27396241
11.
Efficacy and safety of linagliptin in subjects with long-standing type 2 diabetes mellitus (>10 years): evidence from pooled data of randomized, double-blind, placebo-controlled, phase III trials.
Clin Ther
; 36(11): 1595-605, 2014 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25236917
12.
Retinopathy Outcomes With Empagliflozin Versus Placebo in the EMPA-REG OUTCOME Trial.
Diabetes Care
; 42(4): e53-e55, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30705060
13.
Treatment with the dipeptidyl peptidase-4 inhibitor linagliptin or placebo followed by glimepiride in patients with type 2 diabetes with moderate to severe renal impairment: a 52-week, randomized, double-blind clinical trial.
Diabetes Care
; 38(2): e15-7, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25614693
Resultados
1 -
13
de 13
1
Próxima >
>>